欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/V/0579/001
药品名称Gallifen 200 mg/ml Suspension for Use in Drinking Water for Chickens and Pheasants
活性成分
    • fenbendazole 200.0 mg/ml
剂型Oral suspension for use in drinking water
上市许可持有人Huvepharma N.V. Uitbreidingstraat 80 Antwerpen Belgium B-2600
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Gallifen 200 mg/ml Suspension for Use in Drinking Water for Chickens and Pheasants
    • Denmark (DK)
      Gallifen
    • Belgium (BE)
      Gallifen 200 mg/ml
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
      Gallifen 200 mg/ml Suspension zum Eingeben über das Trinkwasser für Hühner
    • France (FR)
      GALLIFEN SUSPENSION POUR ADMINISTRATION DANS L'EAU DE BOISSON POUR POULES
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
      Gallifen 200 mg/ml suspensija lietošanai ar dzeramo ūdeni vistām
    • Lithuania (LT)
      Gallifen, 200 mg/ml suspensija naudoti su geriamuoju vandeniu vištoms
    • Estonia (EE)
      Gallifen
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2019/01/14
最近更新日期2023/08/09
药物ATC编码
    • QP52AC13 fenbendazole
申请类型
  • TypeLevel1:food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Other Generic application Art 13.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase